|12/11/2017 8:35 AM||Save the Date Flyer for the 2018 PA CARES Training Summit, May 2018. |
Attached please find a Save the Date Flyer for the 2018 PA CARES Training Summit. The training summit will take place in May 2018 in Elizabethtown, PA. More information including registration details will be forthcoming.
|12/6/2017 1:54 PM||FREE CERTIFICATION SEMINAR ON COGNITIVE BEHAVIORAL THERAPY (Limited Seating)|
The Department of Drug and Alcohol Programs is pleased to announce a certification seminar in Cognitive Behavioral Therapy (Rational Living Therapy). This comprehensive 3-day seminar, led by Dr. Aldo Pucci, takes the best of the cognitive-behavioral approaches and delivers them in a very systematic manner so attendees can begin implementing it immediately. Dr. Pucci, Psy.D., DCBT is President of the National Association of Cognitive-Behavioral Therapists (http://www.nacbt.org) and founder of the Rational Living Therapy Institute.
Seminars include a comprehensive manual, certification, and 18 continuing education hours from the National Board of Certified Counselors (NBCC), the National Association of Cognitive-Behavioral Therapists (NACBT), and the Pennsylvania Certification Board (PCB). To register, all attendees must agree to a series of 6, one-hour follow-up supervision calls to begin one month following the date of training and continue monthly for a total of six months. These supervision opportunities, to be scheduled by Dr. Pucci, will provide ongoing support in the implementation of learned strategies and ongoing feedback for clinical skill strengthening.
Western region: January 9th, 10th, 11th 2018 - Park Inn by Radisson - 1395 Wayne Ave. Indiana PA 15701
Central region: January 22nd, 23rd, 24th 2018 - Clarion Hotel and Conference Center - 148 Sheraton Dr. New Cumberland, PA 17070
Eastern region: February 6th, 7th, 8th 2018 - Comfort Suites Allentown - 3712 Hamilton Blvd Allentown, PA 18103
Important: Although any clinical professional can attend this seminar, only persons with a Master’s Degree (or graduate student) in a behavioral health profession will receive full CBT certification. Clinicians who do not hold a master’s level degree or higher will receive a paraprofessional certificate. All participants will receive PCB hours.
Seating is limited! Please register now in DDAP’s Training Management System - https://apps.ddap.pa.gov/TMS/
All questions relative to this opportunity can be forwarded to RA-DATRAINING@pa.gov or (717) 736-7452.
|11/22/2017 12:26 PM||ASAM Criteria Transition|
Attached please find correspondence from Acting Secretary Jennifer Smith regarding the ASAM Criteria transition as well as an ASAM FAQ.
|11/16/2017 9:54 AM||New Training Material about Women Veterans Released|
Women are enlisting in the U.S. military at an unprecedented rate. They currently make up around 16 percent of the active duty force, which is the highest rate since the all volunteer force went into effect in 1973. In addition, there are approximately 2 million women veterans in America.
We thank those who have valiantly served our country through the military, and we strive to meet the continuing needs of veterans.
To help behavioral health providers better serve women veterans, the Substance Abuse and Mental Health Services Administration (SAMHSA) just released additional material for the Training Tool Box for Addressing the Gender-specific Service Needs of Women with Substance Use Disorders that focuses on this population. The Training Tool Box is a resource that:
- Serves as a launching board that trainers can use to develop informative, evidence-based trainings about the gender-specific needs of women with substance use disorders (SUDs); and
- Enables trainers to customize workforce learning through fully designed PowerPoint slides, talking points, activities, case studies, resources, and references.
The new supplemental slides can be used to better educate the workforce about women veterans who have SUDs. Featured topics include characteristics of women veterans and current service members, protective and risk factors for SUDs, the needs of women veterans, and recommendations for providers who serve women veterans.
Other related educational resources available on the website include the following:
- Relationships Matter! a webinar series on women's behavioral health that explores the role of relationships in the lives of women experiencing mental health and substance use issues;
- Women Matter! a webinar series that presents current research, best practice, and critical thinking about topics professionals need to know when working with women who have substance use disorders;
- Girls Matter! a webinar series that offers research, best practices, and critical thinking on topics that professionals working with girls and young women must know; and
- Introduction to Women and Substance Use Disorders, a 12-hour, self-paced course developed by SAMHSA that helps counselors and other practitioners working with women better understand women's substance use, treatment, and recovery experiences and effective interventions for women.
All four of these resources provide the option for continuing education credits and can be found on the SAMHSA Women, Children, and Families Training and Technical Assistance website's Trainings page.
We honor all veterans today and thank them for their service!
|10/10/2017 4:02 PM||Workshop: You Are Not Alone: A Workshop for Families Affected by Substance Use and Addiction|
This is a free family workshop coming up on October 14
sponsored by Bridge To Hope and Passavant Hospital Foundation. Below are
links to information on the seminar:
|8/16/2017 2:43 PM||DDAP New Feature - More on Mondays|
See attachment for information released regarding the kick-off event for National Recovery Month.
|8/16/2017 12:10 PM||Preventing Occupational Fentanyl and Fentanyl Analog Exposure to Emergency Responders|
The position of the American College of Medical Toxicology
(ACMT) and American Academy of Clinical Toxicology (AACT), is as follows:
Fentanyl and its analogs are potent opioid receptor agonists, but the risk of
clinically significant exposure to emergency responders is extremely low. To
date, we have not seen reports of emergency responders developing signs or
symptoms consistent with opioid toxicity from incidental contact with opioids.
|7/26/2017 12:49 PM||Policy Bulletin 17-02 - DDAP Prevention Manual Modifications|
Please see attached Policy Bulletin 17-02.
|7/7/2017 1:47 PM||June Edition - The Phoenix Newsletter|
|6/19/2017 9:51 AM||Policy Bulletin 17-01: Historical TEDS Data Entry in PA WITS|
See attached for Policy Bulletin 17-01
|6/19/2017 9:45 AM||Medical Assistance Application Guide|
|5/31/2017 3:01 PM||DDAP Monthly Newsletter|
|5/22/2017 3:49 PM||PA WITS|
Today the Department of Drug and Alcohol Programs (DDAP) announced the official go-live for the new DDAP Data System (PA WITS).
You can stream / download today’s webcast using the links below:
Additional information on PA WITS including: Training, policy bulletin and the Business Associated-Qualified Service Organization Agreement (a.k.a. BAQSOA or QSOA) providers must enter into with FEi can be found at
Signed BAQSOAs should be returned to FEi, Inc at:
• Fax: 410-715-6538
Once FEi receives the agreement, they will activate all of the users for that agency based on the list of user accounts the provider compiled for DDAP several months ago. Users will get an automated email to set up their account.
|5/17/2017 12:58 PM||PA WITS Go-Live Kick Off |
The Department of Drug and Alcohol
Programs (DDAP) is excited to announce the official go-live for the new DDAP Data System (PA WITS) on May
22, 2017. This version of the PA WITS system is being implemented
two-months ahead of schedule for the purposes of collecting TEDS data since
September 1, 2015.
We invite you to join a live streaming
webcast to kick-off the first day of your access to PA WITS. The webcast
will be presented by DDAP project leaders covering important topics
including: policy requirements, e-Training, and how to gain access.
The webcast will be recorded and available for viewing at a later date.
|4/26/2017 11:21 AM||Availability of Free Grief Support Groups|
A PA Advisory Council on Drug and Alcohol
Abuse subcommittee is compiling information on the availability of free
grief support groups statewide that are specifically
tailored for parents, siblings, spouses, etc. that have lost a loved
one to addiction. If you are aware of any such groups, please send the
information to Council member Jennifer Zampogna at firstname.lastname@example.org.
|4/14/2017 9:58 AM||Webinar on the American Society of Addiction Medicine’s (ASAM) Criteria for Clinical and Program Standards |
Centers for Medicare and Medicaid Services (CMS) is hosting a webinar entitled
“Introduction to the American Society of Addiction Medicine (ASAM) Criteria for
Clinical and Program Standards.” The webinar will provide an overview of the
substance use disorder treatment care continuum and standards described in the
American Society of Addiction Medicine (ASAM) Criteria. The webinar will
provide an overview of all the ASAM Criteria levels of care, and then focus
specifically on complex levels of care, including withdrawal management, early
intervention, partial hospitalization, and clinically managed low-intensity
residential services. The webinar will be held on Wednesday, April 19th
from 3:30pm– 5:00pm EST.
for the webinar here.
|4/12/2017 8:19 AM||Frequently Asked Questions |
In preparing for the statewide transition from the
Pennsylvania Client Placement Criteria (PCPC) to the American Society of
Addiction Medicine (ASAM) Criteria, DDAP has prepared the attached list of
Frequently Asked Questions which is also available on its website at the
following location: http://www.ddap.pa.gov/treatment/Pages/ASAM_FAQ.aspx
. Additional questions that are not currently addressed by the FAQ can be
submitted to RA-DATREATMENT@pa.gov
and updates will be made to the website on a regular basis.
|4/6/2017 2:43 PM||DEA National Prescription Drug Take-Back Day - Toolkit Available|
The new toolkit of fliers, posters, brochures, Web ads, and other materials that are typically made available to help advertise the DEA’s National Prescription Drug Take-Back Day is now live at https://www.dea.gov/take-back/takeback-news.shtml. The material is under the “Partnership Toolbox” button on the right-hand side.
Please feel free to pass this info along to your partnering organizations in drug abuse prevention so they can use these toolkit items, push them out to others, and help spread the word about the upcoming take-back day on April 29.
|3/16/2017 7:16 AM||SECRETARY SMITH’S ANNOUNCEMENT REGARDING TRANSITION FROM THE PCPC TO THE ASAM:|
DDAP has, in consultation with the Governor’s Policy Office and the Office of General Counsel, weighed our options for continuing the use of our PCPC (Pennsylvania Client Placement Criteria) tool for determining the appropriate level of care for an individual seeking treatment or already within our treatment system. After weighing the options, we have decided that the benefits of using a customized tool no longer exceed the benefits of using the nationally recognized ASAM (American Society of Addiction Medicine) tool. One reason for the transition stems from the Centers for Medicare & Medicaid Services (CMS) Medicaid Managed Care Final Rule that was issued last summer, which will limit federal reimbursement for residential treatment of Medicaid recipients to 15 days. In response to that rule, and specifically the provision related to the IMD exclusion, Pennsylvania aims to better position ourselves in submitting a 1115 waiver to CMS related to the IMD exclusion. The 1115 waiver application requires the use of the ASAM tool. This issue surrounding the IMD exclusion is not the only reason for making the change, however. The newly acquired treatment data system is already equipped with the ASAM continuum of care which will make this new system more usable with fewer modifications, which limits the risk of future system maintenance issues. Additionally, because the ASAM is currently utilized for placement decisions related to adolescents, and by many commercial insurance providers for both adults as well as adolescents, converting to this tool will create consistency for providers and payers across the treatment system.
While there are multiple advantages to this conversion, we understand that it will not come without its challenges. We have a team of employees who are currently in the process of establishing a strategic plan for transitioning from the PCPC to the ASAM and will be gathering input from stakeholders and establish a workable process that moves us to the use of the ASAM over time, with the goal of full implementation occurring by July 2018. I will continue to keep you posted on the progress and impacts of this effort. I would ask that this become a standing agenda item in our meetings with your membership.
|1/18/2017 10:19 AM||PA Hepatitis C Epidemiologic Profile|
|12/22/2016 9:44 AM||FY 2017 Annual Synar Report |
The Pennsylvania Department of Drug and Alcohol Programs’ FY 2017 Annual Synar Report is currently available for review on the agency’s website: http://www.ddap.pa.gov/Pages/Annual-Reports.aspx . This report is submitted to SAMHSA as a requirement of the Substance Abuse Block Grant and provides information about initiatives aimed at decreasing youth access to tobacco.
In addition to the DDAP website, this report along with the full SAPT Block Grant Application, is available on WebBGAS. To access the block grant reports, log in as "citizenpa" and use "citizen" as your password. Comments can be made at: http://www.ddap.pa.gov/Pages/Contact_Request_Form.aspx
|10/26/2016 3:30 PM||Free Downloadable Media Literacy Curricula for Middle and High School|
DEPARTMENT OF DRUG AND ALCOHOL PROGRAMS ANNOUNCES:
FREE DOWNLOADABLE MEDIA LITERACY CURRICULA
(MIDDLE AND HIGH SCHOOL)
The Department of Drug and Alcohol Programs is pleased to announce that it is making available free, downloadable educational curricula to prevention providers and educators for the purpose of teaching digital and media literacy to middle and high-school students.
The “Media Straight Up! Critical Thinking Skills for Pennsylvania’s Youth” (middle school level) and “Pushing Back: Responding to Representation of Drugs and Alcohol in Popular Culture” (high school level) are curricula that provide specific instructional strategies for raising young people’s awareness and critical thinking skills in responding to mass and social media messages that depict alcohol, tobacco, prescription and illegal drug use. Digital and media literacy skills help students to evaluate the quality and accuracy of what they see, hear and read. They help them recognize how and why media messages appeal to their audience, sharpening awareness of unstated but implied messages.
These media literacy curricula are a resource for any prevention specialist or educator to teach youth about the important skills of digital and media literacy which can contribute to a young person’s ability to understand how media messages affect their perceptions of drugs and alcohol, and may influence the choices they make. Prevention specialists, teachers, school counselors, and community leaders can each play a role in promoting critical thinking to our students about the unhealthy messages they hear and see daily throughout today’s media.
|8/22/2016 10:47 AM||What's Really at Stake - Public Service Campaign from the PA Gaming Control Board|
The Pennsylvania Gaming Control Board has launched a multi-faceted public service campaign to warn youth and parents about the dangers of attempting to gamble at a PA casino when underage. Feel free to disseminate this information on your website, social media sites, etc.
The campaign is titled “What’s Really at Stake” and is designed to raise awareness among youth that it is illegal to gain access to a casino floor in Pennsylvania under the age of 21, convey the numerous consequences of underage gambling, and demonstrate the link between underage gambling and other negative behaviors.
Additionally, the campaign provides messages to parents and friends who all too often facilitate gambling by an underager.
All funding for the What’s Really at Stake campaign is derived from confiscated winnings of voluntary or involuntary excluded patrons who illegally entered a Pennsylvania casino, gained winnings, and were caught in the facility.
|8/5/2016 1:21 PM||PA Open Beds |
Department of Drug and Alcohol Programs (DDAP) has released an innovative tool
to identify available treatment beds for individuals in residential treatment
programs. For more information or to register, you can visit the PA Open Beds page
on our website or email RA-DAOPENBEDS@pa.gov
or call Dan Miller at 717-736-7466.
|8/5/2016 1:20 PM||NALOXONE DISCOUNTS|
DDAP wishes to make our stakeholders
and the general public aware of two discount opportunities for the individual
purchase of naloxone with a prescription or through the use of the Pennsylvania
Physician General’s Standing Order:
the manufacturer of the “Evzio” naloxone auto-injector has announced that they
will minimize the out-of-pocket cost to patients and their family members and
caregivers by providing commercially-insured patients filing a prescription for
EVZIO with an out-of-pocket cost of less than $20 or, in most cases, $0, even
if their commercial insurance plan does not cover EVZIO. This reduced
price is through a pharmacy discount. Additional information about this
reduced price can be found at:
the manufacturer of Narcan Nasal Spray, has partnered with CVS Pharmacy to
offer individuals without insurance a $35 discount coupon available through the
local CVS pharmacy.
requests that this information be shared at large so that individuals are made
aware of these opportunities for obtaining naloxone at a reduced cost.
(Note: DDAP requests that
pharmaceutical companies or pharmacy discount programs notify the Department of
any additional price discounts as they become available so that they can be
added to this announcement.)
|8/4/2016 2:42 PM||Hepatitis C Virus Letter to Providers|
The Department of Drug and Alcohol Programs (DDAP) is
concerned about the rise in hepatitis C cases in Pennsylvania (PA),
particularly among persons who inject drugs (IDU). The Centers for
Disease Control and Prevention recommends hepatitis C virus (HCV) testing for
those who currently inject any type of drug (Opioids, Methamphetamine, Cocaine,
etc.) or have injected drugs in the past, including those who injected once or
a few times many years ago. PA has experienced a dramatic increase in
hepatitis C infections in individuals with injection opioid and/or heroin
addiction who are 18 to 35 years of age. DDAP recommends that all
licensed drug and alcohol addiction treatment facilities perform a risk assessment
for HCV and refer to medical or community based providers for necessary
screening/testing as appropriate.
Because many individuals you serve are at high risk for hepatitis C, you play
an important role in combating this public health issue. If you have
current practices that you believe are effective in combating this disease, we
would appreciate you sharing these with us so we can promote them across the
field. Please send this information to Justin White at email@example.com.
Through improved identification and treatment of individuals with hepatitis C,
we can begin to reduce the spread of this disease. Please remember to
obtain consumer consent and maintain confidentiality when sharing test results
with the consumers’ primary care physicians or other physical health
specialists involved in hepatitis treatment. In some cases, you may be
able to utilize a Qualified Service Organization Agreement (QSOA) to permit the
exchange of patient identifying information. If you have questions about
when this is possible, please contact our Division of Licensing Director,
Treldon Johnson, at firstname.lastname@example.org.
For more information regarding hepatitis C testing of IDU clientele, please
Charles Howsare, MD, MPH
Viral Hepatitis Prevention Coordinator
PA Department of Health
Thank you for your critical assistance in controlling hepatitis C in PA.
Contact Person: Justin White
|6/22/2016 7:42 AM||Expansion Opportunities|
DDAP is currently working with Department of Human Services, Division of Facilities and Property Management to identify locations in the Commonwealth that our Drug and Alcohol provider network might be able to leverage for expansion of services. These locations may be more affordable and require less effort than building a new facility. Current list of available locations is attached. If a provider is interested in seeing the properties available, or would like more information regarding this, please contact Jodi Skiles at email@example.com or 717-736-7454.
|6/22/2016 7:38 AM|| Communication Regarding Naloxone from Kaleo Pharmaceutical |
Please be aware of the following communication/commitment from Kaleo Pharmaceutical for individual persons obtaining naloxone via their pharmacy:
Any commercially insured person with a prescription can now quickly obtain EVZIO with an out-of-pocket cost of, in most cases, $0, even if their insurance does not cover EVZIO. To facilitate this, Kaleo Pharmaceutical has a toll free number, 877-4-EVZIO-EZ, that patients, physicians, or pharmacists can use to get immediate assistance to fill this potentially life-saving prescription.
Feel free to share this information with others.
|6/22/2016 7:37 AM||Medical CMEs for Pennsylvania Health Care Prescribers|
DDAP and the PA Department of Health have been working closely with the PA Medical Society (PAMED) to support their efforts to create a free Continuing Medical Education (CME) related to “Addressing Pennsylvania's Opioid Crisis: What the Health Care Team Needs to Know.” This CME program is divided into four modules and covers a variety of tools and resources for prescribers and dispensers to better address opioid addiction.
- Opioid Prescribing Guidelines
- Naloxone Prescribing
- Referral to Treatment
- In process: Prescription Drug Monitoring Program called the ACHIEVING BETTER CARE BY MONITORING ALL PRESCRIPTIONS PROGRAM or (ABC-MAP)
PAMED has decided to make ALL their opioid CME’s available at no-cost until the end of the 2016 calendar year. Given the extent of the opioid crisis and the urgent need for physicians and other providers to get up to speed on opioid prescribing guidelines, naloxone, referrals to treatment, and the ABC-MAP Program, PAMED wanted to promote this CME to ALL members of the healthcare team that need it. With that in mind, your group may want to consider doing the same if you are currently charging for the series. The link to PAMED’s CME that is includes the test and certificate for CME credits is:
Also, PAMED is going to be developing a 5th module on “Alternative Treatment of Pain” that will highlight non-opioid medication, OT/PT, complementary medicine, and behavior health approaches to managing chronic, non-cancer pain.
|6/10/2016 12:48 PM||SCA Residential Rate Setting Process|
The Department of Drug and Alcohol Programs (DDAP) has been made aware of concerns regarding the rates established between the Single County Authorities (SCAs) and the non-hospital residential detoxification and rehabilitation treatment facilities. To address this issue, DDAP has convened a comprehensive workgroup to identify solutions for the longer term relative to the process and instruments utilized to determine per diem rates. However, for more immediate resolution concerning rates being negotiated for State Fiscal Year 2016/17, DDAP is initiating a two-phase appeals process that allows providers to appeal to the SCA rate setting authority, and failing a satisfactory outcome, the ability to bring appeal to DDAP. This process also allows the SCAs, should negotiations fail to bring about satisfactory result, the ability to appeal to DDAP for final resolution. Attached to this correspondence is a matrix outlining the process for appeal to be followed by both treatment providers and SCAs, as well as the minimum documentation to be submitted with an appeal. Questions that arise in regards to the appeals process may be directed to the resource account established for this process and denoted on the attachment.